Zoetis (ZTS) Common Equity (2012 - 2026)

Zoetis (ZTS) has 15 years of Common Equity data on file, last reported at $3.2 billion in Q1 2026.

• On a quarterly basis, Common Equity fell 33.55% year-over-year to $3.2 billion in Q1 2026; TTM through Mar 2026 was $3.2 billion, a 33.55% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 29.5% from the prior year.
• Common Equity for Q1 2026 stood at $3.2 billion, down from $3.4 billion in the prior quarter.
• Over the last five years, Common Equity for ZTS reached as high as $5.4 billion in Q3 2025 and fell as low as $3.2 billion in Q1 2026.
• Historically, Common Equity has averaged $4.7 billion across 5 years, with a median of $4.8 billion in 2024.
• Across the five-year window, Common Equity advanced 13.83% in 2022 and sank 33.55% in 2026, its largest moves.
• Year by year, Common Equity stood at $4.4 billion in 2022, then advanced by 13.35% to $5.0 billion in 2023, then retreated by 2.95% to $4.8 billion in 2024, then slipped by 29.5% to $3.4 billion in 2025, then dropped by 5.33% to $3.2 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $3.2 billion in Q1 2026, $3.4 billion in Q4 2025, and $5.4 billion in Q3 2025.